- Home
- TIL vs BNTC Comparison
TIL vs BNTC Comparison
Compare TIL & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- BNTC
- Stock Information
- Founded
- TIL 2018
- BNTC 1995
- Country
- TIL United States
- BNTC United States
- Employees
- TIL N/A
- BNTC N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- TIL Health Care
- BNTC Health Care
- Exchange
- TIL Nasdaq
- BNTC Nasdaq
- Market Cap
- TIL 230.1M
- BNTC 366.6M
- IPO Year
- TIL 2021
- BNTC N/A
- Fundamental
- Price
- TIL $28.30
- BNTC $13.17
- Analyst Decision
- TIL Buy
- BNTC Strong Buy
- Analyst Count
- TIL 5
- BNTC 6
- Target Price
- TIL $119.00
- BNTC $23.83
- AVG Volume (30 Days)
- TIL 349.6K
- BNTC 226.1K
- Earning Date
- TIL 08-12-2025
- BNTC 05-14-2025
- Dividend Yield
- TIL N/A
- BNTC N/A
- EPS Growth
- TIL N/A
- BNTC N/A
- EPS
- TIL N/A
- BNTC N/A
- Revenue
- TIL N/A
- BNTC N/A
- Revenue This Year
- TIL N/A
- BNTC N/A
- Revenue Next Year
- TIL N/A
- BNTC N/A
- P/E Ratio
- TIL N/A
- BNTC N/A
- Revenue Growth
- TIL N/A
- BNTC N/A
- 52 Week Low
- TIL $9.62
- BNTC $7.05
- 52 Week High
- TIL $92.00
- BNTC $17.15
- Technical
- Relative Strength Index (RSI)
- TIL 46.80
- BNTC 41.76
- Support Level
- TIL $20.60
- BNTC $10.91
- Resistance Level
- TIL $25.95
- BNTC $12.74
- Average True Range (ATR)
- TIL 3.47
- BNTC 1.33
- MACD
- TIL -1.29
- BNTC -0.31
- Stochastic Oscillator
- TIL 22.74
- BNTC 31.66
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.